Skip to main content

Day: August 18, 2021

Bowlero Corp Completes Acquisition of Bowl America

Expands Digital Gaming & Sports Media Efforts RICHMOND, Va., Aug. 18, 2021 (GLOBE NEWSWIRE) — Bowlero Corp (“Bowlero”), the world’s largest owner and operator of bowling centers as well as owner of the Professional Bowlers Association (PBA), today announced that it has completed its acquisition of Bowl America (NYSE American: BWL-A) and its 17 bowling centers in Florida, Virginia and Maryland. Total consideration for the transaction is approximately $44 million. The Bowl America acquisition is Bowlero Corp’s latest strategic growth initiative following last month’s announcement of plans to list on the NYSE through a merger with Isos Acquisition Corporation (NYSE: ISOS.U, “Isos”). Upon the closing of the transaction with Isos – expected in October 2021 – Bowlero’s common stock and warrants are expected to trade on NYS under...

Continue reading

The Topps Company Raises 2021 Outlook and Announces Second Quarter 2021 Results

Raises Full Year 2021 OutlookNet Sales Increased 77.7% to $212.2 Million Net Income Increased 176.4% to $36.3 MillionAdjusted EBITDA* Increased 144.0% to $55.1 Million NEW YORK, Aug. 18, 2021 (GLOBE NEWSWIRE) — The Topps Company, Inc. (“Topps” or “the Company”), a global leader in sports and entertainment collectibles and confections, today announced financial results for the second quarter ended July 3, 2021. Second Quarter 2021 Financial HighlightsComparison of the Thirteen Weeks Ended July 3, 2021 to the Thirteen Weeks Ended July 4, 2020Net sales increased by $92.8 million, or 77.7%, to $212.2 million Gross margin improved 350 basis points to 43.3% Net income grew 176.4% to $36.3 million Adjusted EBITDA* grew 144.0% to $55.1 million Adjusted EBITDA margin* increased 710 basis points to 26.0%Second Quarter 2021 Segment HighlightsComparison...

Continue reading

Eve & Co. Announces Medical Cannabis Supply & Purchase Agreement with Australian Distributor TCann Pty Ltd.

STRATHROY, Ontario, Aug. 18, 2021 (GLOBE NEWSWIRE) — Eve & Co Incorporated (“Eve & Co”, “we”, “us” or the “Company”) (TSX-V: EVE; OTCQX: EEVVF), is pleased to announce that its wholly-owned subsidiary, Natural MedCo Ltd. (“NMC”) has successfully entered into a Medical Cannabis Supply and Purchase Agreement (the “Agreement”) with TCann Pty Ltd., Australia (“TCann”), an import/export and distribution company of para-pharmaceutical, medicinal and narcotic products located in Thornleigh, New South Wales. Pursuant to the Agreement, NMC will supply medical grade dried cannabis flower to TCann and TCann will distribute NMC medical grade dried cannabis products in Australia. TCann is a licensed cultivator and manufacturer of medicinal cannabis products. TCann focuses on producing high quality pharmaceutical-grade cannabis products...

Continue reading

Mydecine Innovations Group signs five-year Master Collaboration Research Agreement with Johns Hopkins University School of Medicine

Agreement allowing work on numerous collaborative research initiatives in the coming years DENVER, Aug. 18, 2021 (GLOBE NEWSWIRE) — Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) announces it has signed a five-year research agreement with Johns Hopkins University (JHU) School of Medicine, with research to be led by Professor of Psychiatry and Behavioral Sciences at Johns Hopkins University, Dr. Matthew W. Johnson, Ph. D. The Johns Hopkins Behavioral Pharmacology Research Unit has extensive experience conducting clinical research related to therapeutic use of psychedelics.   Mydecine CEO Josh Bartch said, “We are excited to expand on the current work we are conducting with Dr. Matt Johnson and his team at JHU in regards to smoking cessation to include numerous other projects over the next five years. The researchers at JHU...

Continue reading

Psyence Group Announces the Commencement of Online Sales and Distribution of “GOODMIND” Products

GOODMIND™Psyence Group Announces the Commencement of Online Sales and Distribution of “GOODMIND” ProductsTORONTO and CAPE TOWN, South Africa, Aug. 18, 2021 (GLOBE NEWSWIRE) — Psyence Group Inc. (CSE: PSYG) (“Psyence” or the “Company”), a life science biotechnology company pioneering the use of natural psychedelics in mental health and well-being, is pleased to announce the commencement of online sales and distribution of its premium range of functional mushroom products, GOODMIND™. The GOODMIND™ formulas harness the power of adaptogens; non-toxic, non-psychoactive fungi, used for centuries in traditional medicine for their stress-relieving benefits. GOODMIND™ is designed to nourish the mind and elevate everyday life by enhancing mental capacity and the body’s ability to adapt to stress. Psyence has partnered with...

Continue reading

Baltic Horizon will hold an Investor Conference Webinar to introduce the results for H1 2021

Baltic Horizon Fund invites unitholders, investors, analysts and other stakeholders to join its investor conference webinar, scheduled on 26 August 2021 at 13:00 PM (CET) or 14:00 PM (EET). The webinar will be hosted by Tarmo Karotam, the Fund Manager of Baltic Horizon Fund. Q&A session will follow after the presentation. Due to limited webinar time, we encourage participants to send their questions no later than one day before the webinar to tarmo.karotam@nh-cap.com. To join the webinar, please register via the following link:  https://register.gotowebinar.com/register/3139815299395792397 You will be provided with the webinar link and instructions how to join successfully. When joining the webinar for the first time, you will be asked to download the plug-in which will take only few seconds. In case plug-in can’t be downloaded,...

Continue reading

MediPharm Labs Receives Export Authorization to Ship Medical Cannabis to Brazil

Completed the regulatory process required to ship medical cannabis to Brazil with import permits issued from ANVISA and export permits issued from Health Canada. Initial deliveries will be under the compassionate care program. First shipments to Brazil to be used for patient trials to collect data that may be used in future product marketing authorizations under Brazil’s medical cannabis program. A program that saw over 20,000 patients in 2020 and is growing by 1,500 patients a month.BARRIE, Ontario, Aug. 18, 2021 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a pharmaceutical company that specializes in cannabis, is pleased to announce that it has received approval to ship medical cannabis oil to Brazil. This approval, issued by both ANVISA and Health Canada,...

Continue reading

Wabash Trenching Returns Significantly Higher Silver Results with up to 199 g/t Ag along with Cu (1.90%), Pb (1.27%) and Au (2.43 g/t)

Figure 1Wabash property – June 2021 grab samples resultsMONTREAL, Aug. 18, 2021 (GLOBE NEWSWIRE) — Kintavar Exploration Inc. (the “Corporation” or “Kintavar”) (TSX-V: KTR), is very pleased to announce the results from the trenching in the Indiana area where mineralization was earlier discovered in the summer. The three trenches in the Indiana area are along strike and extend over 500m with mineralization observed within interbedded metric calcitic marbles and paragneissic units. The major sulfides associated with the mineralization are chalcopyrite, bornite-covellite, sphalerite and galena which are all indicative of additional enrichment patterns within the stratiform copper sequence. The Corporation is working with its technical advisor Dr. Michel Gauthier define the controls of the mineralized system and develop...

Continue reading

Baltic Horizon will hold an Investor Conference Webinar to introduce the results for H1 2021

Baltic Horizon Fund invites unitholders, investors, analysts and other stakeholders to join its investor conference webinar, scheduled on 26 August 2021 at 13:00 PM (CET) or 14:00 PM (EET). The webinar will be hosted by Tarmo Karotam, the Fund Manager of Baltic Horizon Fund. Q&A session will follow after the presentation. Due to limited webinar time, we encourage participants to send their questions no later than one day before the webinar to tarmo.karotam@nh-cap.com. To join the webinar, please register via the following link:  https://register.gotowebinar.com/register/3139815299395792397 You will be provided with the webinar link and instructions how to join successfully. When joining the webinar for the first time, you will be asked to download the plug-in which will take only few seconds. In case plug-in can’t be downloaded,...

Continue reading

ProMIS Neurosciences Inc. Announces Pricing of US$15 Million Public Offering of Units

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Aug. 18, 2021 (GLOBE NEWSWIRE) — ProMIS Neurosciences Inc.  (“ProMIS” or the “Company”) (TSX: PMN), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oligomers implicated in the development of neurodegenerative diseases, is pleased to announce the pricing of its previously announced public offering (the “Offering”). Pursuant to the Offering, the Company will issue up to 93,750,000 units (the “Units”) at a price of US$0.16 per Unit (the “Issue Price”) for aggregate gross proceeds of US$15 million, exclusive of the Agent’s Option (as defined herein) and before deducting the Agent’s Cash Commission (as defined herein) and estimated Offering expenses payable by the Company. Each Unit...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.